Endometrial responses to three different progestins in artificial cycles: a prospective, crossover study

Li, Tin‐Chiu; Aplin, John D.; Warren, Alistair; Graham, R.; Dockery, Peter; Cooke, I. D.

doi:10.1016/s0015-0282(16)56840-x

Cited by 5 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This result was unexpected because all progestins were used at a dosage equivalent to 10 mg MPA; therefore, they were supposed to have a comparable effect. It is possible that different progestins have a different effect on the endometrium, 21,22 leading to a different clinical response. However, no study has directly compared the endometrial effects between these progestins.…”

Section: Discussionmentioning

confidence: 99%

Clinical and pathological responses of progestin therapy for non‐atypical endometrial hyperplasia: A prospective study

Rattanachaiyanont

Angsuwathana

Techatrisak

et al. 2005

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical and pathological responses of progestin therapy for non‐atypical endometrial hyperplasia: A prospective study

Rattanachaiyanont

Angsuwathana

Techatrisak

et al. 2005

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…Large quantities of cell-associated KS are found in the endometrial lining during the menstrual cycle and have an important role during embryo implantation. Specifically, the antiadhesive properties of KS have important roles in both endothelial cell migration in cornea epithelium and in embryo implantation during the menstrual cycle [ 127 – 129 ]. Several reviews describe possible structures and functions of KS-PGs [ 130 – 132 ], but the role of KS-PGs in drug delivery is not known clearly.…”

Section: Gags/pgs In Drug Deliverymentioning

confidence: 99%

Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery

Misra

Hascall

Atanelishvili

et al. 2015

International Journal of Cell Biology

View full text Add to dashboard Cite

The outcome of patients with cancer has improved significantly in the past decade with the incorporation of drugs targeting cell surface adhesive receptors, receptor tyrosine kinases, and modulation of several molecules of extracellular matrices (ECMs), the complex composite of collagens, glycoproteins, proteoglycans, and glycosaminoglycans that dictates tissue architecture. Cancer tissue invasive processes progress by various oncogenic strategies, including interfering with ECM molecules and their interactions with invasive cells. In this review, we describe how the ECM components, proteoglycans and glycosaminoglycans, influence tumor cell signaling. In particular this review describes how the glycosaminoglycan hyaluronan (HA) and its major receptor CD44 impact invasive behavior of tumor cells, and provides useful insight when designing new therapeutic strategies in the treatment of cancer.

show abstract

The role of androgens and the androgen receptor in cycling endometrium

Cloke

Christian

2012

Molecular and Cellular Endocrinology

View full text Add to dashboard Cite

Endometrial responses to three different progestins in artificial cycles: a prospective, crossover study

Cited by 5 publications

References 4 publications

Clinical and pathological responses of progestin therapy for non‐atypical endometrial hyperplasia: A prospective study

Clinical and pathological responses of progestin therapy for non‐atypical endometrial hyperplasia: A prospective study

Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery

The role of androgens and the androgen receptor in cycling endometrium

Contact Info

Product

Resources

About